Loading...
 

Volume 31, Issue 4, December 2020




Sign in to download the Issue in PDF format.

Mediterr J Rheumatol 2020;31(4):384-8
Rheumatoid Arthritis: Defining Clinical and Ultrasound Deep Remission
Authors Information

Arthritis Unit, Rheumatology and Autoimmune Diseases Department, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain

Hèctor Corominas, Cesar Diaz-Torne

Abstract
The prognosis of patients with rheumatoid arthritis (RA) has improved substantially in the last two decades due to the appearance of biological therapies, but above all, due to the improvement in the strategy and management of the disease. Our goal in RA should be to achieve remission, or in its absence, the lowest inflammatory activity. Achieving remission will prevent from structural and functional damage highly associated with RA itself. Clinical remission is defined as the absence of significant signs and symptoms of inflammatory disease activity, as well as the abrogation of any signs of systemic inflammation. Currently, there are some controversies about remission. Which is the real remission? Which remission criteria should be used and when? Does clinical remission mean ultrasound remission? In the present review, we try to answer and put some light into it, focusing on clinical and ultrasound deep remission.

Article Submitted: 29 May 2020; Revised Form: 5 Oct 2020; Article Accepted: 13 Oct 2020; Available Online: 28 Dec 2020

https://doi.org/10.31138/mjr.31.4.384

This work is licensed under a Creative Commons Attribution 4.0 International License (CC-BY). 

©Corominas H, Millan AM, Diaz-Torne C.